OBJECTIVE -Elevated heart rate has been predictive of cardiovascular disease and has been proposed as a global index of the autonomic nervous system influence on the heart. Hyperinsulinism has been shown to trigger sympathetic activity experimentally; however, the clinical and epidemiological data on the association of heart rate with hyperinsulinism and insulin resistance are conflicting.
E
levated heart rate has been predictive of cardiovascular disease and total or cardiovascular mortality (1) (2) (3) . Heart rate has been proposed as a global index of the autonomic nervous system influence on the heart (4), and elevated heart rate may reflect a shift in autonomic balance toward enhanced sympathetic and suppressed vagal tone. Hyperinsulinism has been shown to trigger sympathetic activity experimentally (5-7); however, the clinical and epidemiologic data on the association of heart rate with hyperinsulinism and insulin resistance are conflicting (8) (9) (10) (11) (12) .
Herein, we sought to investigate the relation of heart rate to fasting insulin, its precursors (intact and split proinsulin), as well as insulin sensitivity (S I ) and the acute insulin response (AIR). This was measured by a frequently sampled intravenous glucose tolerance test (FSIGTT) and minimal model analysis, in a large tri-ethnic nondiabetic population (n = 1,000). The focus of this study is on nondiabetic individuals to simplify the analysis and because previous studies have shown 1) a strong association of postload glucose levels with heart rate (9) and 2) a limited range of S I in patients with type 2 diabetes (13) .
RESEARCH DESIGN AND METHODS

Patients and methods
A full description of the design and methods of the Insulin Resistance Atherosclerosis Study (IRAS) has been published (14) .
A total of 1,088 nondiabetic individuals participated in the IRAS. Subjects taking drugs influencing heart rate (antiarrhythmics, ␤-blockers, tri-and tetracyclic antidepressants) were excluded from the analysis (n = 88). Thus, this article includes data on 1,000 nondiabetic subjects (Table 1) . Height, weight, girths (minimum waist and hips), and blood pressure (BP) were measured following standardized procedures. Hypertension was defined as systolic BP Ն140 mmHg and/or diastolic BP Ն90 mmHg or current use of antihypertensive medication. Cigarette smoking (none, past, or current smoking) and physical activity (frequency of vigorous activity using 5 predefined responses from "rarely-to-never" to "5 or more times per week") were assessed using a standard questionnaire.
Electrocardiograms (ECGs) were recorded after a strictly standardized protocol on the day the oral glucose tolerance test (OGTT) was performed. The ECG was recorded as soon as possible and no later than 45 min after the glucose ingestion to avoid confounding by glucose resorption. A bioelectrical impedance measurement procedure (supine position, lasting ϳ10 min) preceded the ECG recording. The heart rate was determined using the portable MAC/PC electrocardiograph (Marquette Electronics, Milwaukee, WI). The computer program uses successive R-R intervals between all Festa and Associates ventricular muscle depolarizations (QRS complexes) in the standard 12-lead resting supine ECG to calculate the mean heart rate within the recording period of 10 s. These principles also applied for subjects with arrhythmias and extrasystoles.
The IRAS examination required 2 visits. Before each visit, patients were asked to fast for 12 h, to abstain from heavy exercise and alcohol for 24 h, and to refrain from smoking the morning of the examination. A standard 75-g OGTT was performed and glucose tolerance status was based on the World Health Organization criteria (15) . Plasma glucose, insulin, proinsulin, and S I were measured as described previously (14) . AIR was calculated as the mean of 2-and 4-min insulin concentrations after glucose administration.
Statistical analysis
Statistical analyses were performed using the SAS statistical software system (SAS, Cary, NC). Spearman rank correlations were calculated. Potentially confounding covariates (age, sex, ethnicity, smoking, glucose tolerance status, blood pressure, and physical activity) were included in multivariate analyses. Partial Spearman correlation analyses were also stratified by sex, glucose tolerance status, ethnicity, and hypertension. We also tested for interactions between sex, ethnicity, and glucose tolerance status and fasting insulin, proinsulin (intact, split), the proinsulin-to-insulin ratio, AIR, and S I , respectively, in association with heart rate by calculating interaction terms (sex ϫ fasting insulin, ethnicity ϫ fasting insulin, etc.).
Because we found no significant interactions between sex, glucose tolerance status, and the variables of interest, pooled analyses are presented.
Multiple linear regression models were performed, including all variables of interest at the same time as independent variables to demonstrate the relative contribution of each of these variables to the outcome variable. After age, sex, ethnicity, clinic, glucose tolerance status, and smoking were forced into the model, the following independent variables were considered for the model: fasting insulin, proinsulin (intact, or in separate models split proinsulin), AIR, and S I . Only variables with a P value of Յ0.05 were considered in the final fitted model (Table 3) . Finally, linear regression models were fit including systolic BP, physical activity, or both as additional covariates.
P values Ͻ0.05 (2-sided) were considered statistically significant.
RESULTS
Spearman correlation analysis
Unadjusted correlation analysis showed a significant relationship among heart rate and BMI (r = 0.15), waist (r = 0.08), waistto-hip ratio (WHR) (r = Ϫ0.08), fasting insulin (r = 0.22), intact proinsulin (r = 0.15), split proinsulin (r = 0.18), S I (r = Ϫ0.21), and AIR (r = 0.14). Partial analyses ( Table 2) showed correlation coefficients comparable to those of the unadjusted analyses, with the exception of WHR, which was positively associated with heart rate in the partial analysis.
Stratified analysis by ethnicity
Fasting insulin and AIR were related to heart rate in all 3 ethnic groups. The relationship between S I and heart rate was more pronounced and significant only in Hispanics (Hs) and non-Hispanic whites (NHWs) as compared with African-Americans (AAs) (interaction term, P = NS). Heart rate was related to proinsulin (intact and split) only in H and NHW but not in AA (interaction term, P = 0.02 for intact proinsulin and P = 0.03 for split proinsulin) individuals. These ethnic differences were consistently seen after further adjustment for systolic BP and physical activity (data not shown).
Stratified analysis by hypertension
In both hypertensive (HT) (n = 291) and normotensive (NT) (n = 709) subjects, Heart rate, insulin resistance, and insulin secretion heart rate was significantly related to fasting insulin (r = 0.15, P Ͻ 0.05 in HT; r = 0.22, P Ͻ 0.0001 in NT), split proinsulin (r = 0.18, P Ͻ 0.005 in HT; r = 0.16, P Ͻ 0.0001 in NT), AIR (r = 0.18, P Ͻ 0.005 in HT; r = 0.17, P Ͻ 0.0001 in NT), and S I (r = Ϫ0.24, P Ͻ 0.0001 in HT; r = Ϫ0.16, P Ͻ 0.0001 in NT). Intact proinsulin was significantly related to heart rate in NT (r = 0.15, P Ͻ 0.0005) and reached borderline significance in HT (r = 0.11, P = 0.08).
Multiple linear regression analysis
Significant independent determinants of heart rate were AIR, proinsulin (intact as well as split [data not shown]), and S I (Table 3) . After further adjustment for systolic BP or physical activity, AIR and proinsulin, but not S I (P Ͻ 0.15), remained significant determinants of heart rate, as well as in the final model, including all potentially confounding covariates (Table 4) .
CONCLUSIONS -
The novel finding of the present study is the independent association of heart rate with first-phase insulin secretion, as assessed by an FSIGTT. Furthermore, heart rate was related to proinsulin in H and NHW, but not in AA individuals. Additionally, heart rate was inversely related to S I , and this relation was attenuated after adjusting for blood pressure or physical activity.
A positive association of heart rate and the plasma insulin response to oral glucose has been reported previously in middleaged NT nondiabetic individuals (10). However, time-points of insulin sampling were not reported; therefore, it cannot be determined whether this association reflects insulin resistance or insulin secretion (16) . A positive association of heart rate with fasting insulin, as a potential marker of insulin resistance (17) , has been reported repeatedly (8, 9) , but studies on the association of heart rate with S I , as assessed by direct measures, are controversial. Moan et al. (18) report a negative association of heart rate with S I , as measured by a clamp technique, in young healthy men (n = 40) only in univariate analysis. Facchini et al. (10) , using an insulin suppression test, found a negative association of S I with average heart rate during sleep in middle-aged NT nondiabetic individuals (n = 45) also in multivariate analysis. In contrast to these reports, in young NT nondiabetic individuals, no association of mean heart rate during 24 h with S I , as measured by an FSIGTT, was found (12) . In Japanese subjects, the sum of insulin during an OGTT, as a surrogate marker of insulin resistance, showed a weak association (P Ͻ 0.09) with resting heart rate (11) . Results of these studies have to be interpreted with caution because of small sample size (8, 9) or the use of surrogate markers of insulin resistance (10) (11) (12) 18) , rather than more specific direct measures of S I .
Resting heart rate is a marker of hemodynamic and autonomic nervous system states (19) and has been suggested as an integrated index of autonomic nervous system influences on the heart (4). There are several lines of evidence linking sympathetic nerve activity with insulin resistance and hyperinsulinemia. The sequence of pathophysiological events over time, however, is unknown.
Assuming that the initial event is sympathetic overactivation, insulin resistance and/or impaired insulin secretion would fol- low secondarily. Selective sympathetic activation in skeletal muscle/reduced insulininduced stimulation of glucose uptake (20) . The relationship of sympathetic nerve activity and insulin secretion is even more complex, partly due to differential sympathetic effects on pancreatic ␣-and ␤-adrenergic receptors. Acute adrenergic stimuli, such as insulin-induced hypoglycemia, markedly blunt insulin secretion, mainly via ␣ 2 -receptors, but catecholamines in low concentrations potentially stimulate insulin secretion by activating ␤ 2 -receptors (21). Alternatively, one might also assume that sympathetic overactivation is not the cause but rather the consequence of hyperinsulinemia and/or insulin resistance. Although it is well established that acute short-term insulin infusion (5) (6) (7) 22, 23) stimulates sympathetic nerve activity, including an increase in heart rate (23), the impact of chronic hyperinsulinemia is conflicting in animals (24,25) and unknown in humans.
Finally, a common underlying process may exist, triggering both sympathetic nerve activity and insulin resistance, such as thinness at birth. Heart rate in middleaged individuals was inversely related to birth weight, leading to the hypothesis that elevated sympathetic nerve activity established in utero may be one mechanism linking small size at birth with the insulin resistance syndrome in adult life (26) .
The question of whether an improvement in S I by pharmacological or nonpharmacological interventions leads to a decrease in heart rate has, to our knowledge, not been addressed in a prospective study. In hyperlipidemic rabbits, however, treatment with the insulin-sensitizing drug troglitazone reduced heart rate (27) , and in 24 obese HT subjects, weight loss within 4 weeks resulted in increased S I and decreased heart rate (28) .
There are several possible explanations for the association of proinsulin with heart rate as shown in the present study. First, if proinsulin is a marker of insulin secretion (29) , the view that insulin secretion contributes to heart rate, as discussed above, would be supported. Second, although the biological potency of proinsulin is only ϳ10% that of insulin, in terms of its glucose-lowering effect (30) , its potency may be considerably higher in terms of other effects, and proinsulin split products may even be biologically more potent than intact proinsulin (31) . The sympatheticoexcitatory effects of insulin are conceivably mediated via a central neural action (32) and insulin receptors have been identified in several regions of the central nervous system (33) . It is well known that proinsulin acts through insulin receptors (31); however, to our knowledge, no data on central nervous effects of proinsulin have been reported. It is interesting to note that the sympathetico-excitatory effect of insulin, including an increase in heart rate, is operative even at modestly elevated plasma levels (6, 34) , corresponding to insulin levels that can be observed in the postprandial state (25 µU/ml) (34) . Also, it has been shown that, in both patients with type 2 diabetes and in nondiabetic healthy subjects, circulating proinsulin levels were associated with the sympathovagal balance of autonomic nervous function, as assessed by analysis of heart rate variability (35) . Therefore, even small differences in circulating proinsulin levels may be of pathophysiological significance in terms of influencing sympathetic nerve activity. Finally, proinsulin may also be a proxy of S I in nondiabetic subjects (29) .
In summary, we have shown an association of heart rate with proinsulin, AIR, and S I in nondiabetic subjects. Prospective studies are needed to determine the clinical significance of these findings.
